| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |